Global Antidepressants Market Report 2022 – Market Forecast, Trends And Strategies

The global antidepressants market size is expected to grow from $15.61 billion in 2021 to $16.44 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The change in the market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The antidepressants market is expected to reach $22.57 billion in 2026 at a CAGR of 8.2%.

What is the Global Antidepressants Market?

The antidepressants market consists of sales of antidepressants and related services that are used in retail pharmacies, hospitals and clinics. Antidepressants are drugs that can help to alleviate depressive symptoms, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or moderate persistent depressive, as well as other conditions. The antidepressant medications available include the antagonists of SSRIs or selective serotonin reuptake, MAOIs or monoamine oxidase inhibitors, tricyclic antidepressants, tetracyclic antidepressants and others.

Get a Sample of the global antidepressants market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2881&&type=smp

What drives the Global Antidepressants Market?

The antidepressants market has also surged during the COVID-19 outbreak. The increasing number of cases and fatalities is affecting the mental health by elevating anxiety worldwide. People who are already living with mental health problems are experiencing increased stress levels over the COVID-19 outbreak. This has triggered the demand for antidepressant drugs.

Get the full global antidepressants industry report here:

Global Antidepressants Market Segments
The global antidepressants market is segmented:
By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
By Geography: The regions covered in the antidepressants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Antidepressants Global Market Report 2022provides market size and growth forecasts for the global antidepressants market, global antidepressants market share, antidepressants market segments and geographies, antidepressants market competitive landscape including leading competitors’ revenues, profiles and market shares. The antidepressants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Antidepressants Industry Playersinclude Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd, Alkermes, Bristol Myers Squibb Company, Teva Pharmaceutical Industries, Eli Lilly and Co., Takeda Pharmaceutical Co. Ltd, Forest laboratories and Akeda Pharmaceutical. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.